ChemFeeds Site Navigation:
Journal Selection:
Search:

1) IL15-Secreting MSCs Exert Antitumor Potential (Molecular Cancer Therapeutics) Tuesday August 5th 2014


2) TDP1 and TDP2 Inhibitor Screening (Molecular Cancer Therapeutics) Tuesday August 5th 2014


3) CENP-E Motor Function in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Tuesday August 5th 2014


4) Mechanism of Action of the Novel Taxane Cabazitaxel (Molecular Cancer Therapeutics) Tuesday August 5th 2014


5) TGF-Stimulated Mesothelial Cells in Ovarian Cancer Progression (Molecular Cancer Therapeutics) Tuesday August 5th 2014


6) DDX43 Induces RAS Signaling and Drug Resistance (Molecular Cancer Therapeutics) Tuesday August 5th 2014


7) PP2A Inhibitor Sensitizes HCC to Chemotherapy (Molecular Cancer Therapeutics) Tuesday August 5th 2014


8) FAK Controls Ovarian Carcinoma Spheroid Growth (Molecular Cancer Therapeutics) Tuesday August 5th 2014


9) Activity of RG7787 in Pancreatic Cancer Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


10) Bispecific HER2-Targeting FynomAb with Superior Activity (Molecular Cancer Therapeutics) Tuesday August 5th 2014


11) s50-TBG-RNAi-CK2 Targets Primary and Metastatic HNSCC (Molecular Cancer Therapeutics) Tuesday August 5th 2014


12) Novel Drug for Treatment of Temozolomide-Resistant Gliomas (Molecular Cancer Therapeutics) Tuesday August 5th 2014


13) AKI603 Attenuates Breast Tumor Initiating Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


14) AR-42 Targets AML Stem Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


15) A Pragmatic Definition of Therapeutic Synergy (Molecular Cancer Therapeutics) Monday July 7th 2014


16) miR-3607 in Prostate Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


17) miR26b Regulates Cancer Proliferation (Molecular Cancer Therapeutics) Monday July 7th 2014


18) Repositioning Drugs for Renal Cell Cancer Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


19) Mutation Profile of Melanomas Lacking Known Driver Mutations (Molecular Cancer Therapeutics) Monday July 7th 2014


20) BET Bromodomain Inhibition and Pancreatic Cancer Progression (Molecular Cancer Therapeutics) Monday July 7th 2014


21) Antiproliferative Synergism of CK2 and BRAF Inhibitors (Molecular Cancer Therapeutics) Monday July 7th 2014


22) Targeting ER{beta} in SERM-Resistant Breast Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


23) LXR Inhibition of Myeloma Stem Cells (Molecular Cancer Therapeutics) Monday July 7th 2014


24) SIRT1 in the Antitumor Activity of Silybin (Molecular Cancer Therapeutics) Monday July 7th 2014


25) ABT-737 Enhances MEK/mTOR Inhibition-Induced AML Apoptosis (Molecular Cancer Therapeutics) Monday July 7th 2014


26) PIK3R3 Induces EMT, Promoting Metastasis of Colorectal Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


27) MM-121 Combined with Cetuximab in HNSCC Preclinical Models (Molecular Cancer Therapeutics) Monday July 7th 2014


28) Prostate Cancer-Targeted Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


29) Pretargeted RIT of GD2 with an Anti-GD2/DOTA IgG-scFv (Molecular Cancer Therapeutics) Monday July 7th 2014


30) Anti-sEcad mAb-Induced Suppression of Skin SCCs (Molecular Cancer Therapeutics) Monday July 7th 2014


31) Generation of a Canine Anti-EGFR Antibody (Molecular Cancer Therapeutics) Monday July 7th 2014


32) Antibody-Based Delivery of IL2 and Cytotoxics (Molecular Cancer Therapeutics) Monday July 7th 2014


33) Targeting Pancreatic Cancer Stem Cells (Molecular Cancer Therapeutics) Monday July 7th 2014


34) Effect of Metronomic Docetaxel in PRINT Particles and siEZH2 (Molecular Cancer Therapeutics) Monday July 7th 2014


35) Redox-Active Cerium Oxide Nanoparticles in Cancer Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


36) Anti-miR182 Treatment in Ovarian Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


37) GGA Exerts Cardioprotective and Anticancer Effects (Molecular Cancer Therapeutics) Monday July 7th 2014


38) EW-7197, an Antimetastatic Drug in Breast Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


39) Leelamine Inhibits Intracellular Cholesterol Transport (Molecular Cancer Therapeutics) Monday July 7th 2014


40) Targeting Melanomas Using Leelamine (Molecular Cancer Therapeutics) Monday July 7th 2014


41) Correction: Characterisation of the Novel Apoptotic and Therapeutic Activities of the Histone Deacetylase Inhibitor Romidepsin (Molecular Cancer Therapeutics) Thursday June 5th 2014


42) Efficacy of Zibotentan in Colorectal Cancer--Response (Molecular Cancer Therapeutics) Thursday June 5th 2014


43) Efficacy of Zibotentan in Colorectal Cancer--Letter (Molecular Cancer Therapeutics) Thursday June 5th 2014


44) 3D Environment in Chemoresistance of GBM Stem-like Cells (Molecular Cancer Therapeutics) Thursday June 5th 2014


45) ABT-737 Mediates Dislocation of ER Luminal Proteins (Molecular Cancer Therapeutics) Thursday June 5th 2014


46) PARP Inhibitors' Off-Target Effects (Molecular Cancer Therapeutics) Thursday June 5th 2014


47) Aflibercept versus Bevacizumab in PDX Colorectal Cancer Tumors (Molecular Cancer Therapeutics) Thursday June 5th 2014


48) MLN4924 DNA-Damaging Agent Combinations (Molecular Cancer Therapeutics) Thursday June 5th 2014


49) KRAS Status Predicts Antifolate Sensitivity (Molecular Cancer Therapeutics) Thursday June 5th 2014


50) Antibody-Drug Con{#x0237}ugate BRAF Inhibitor Combination (Molecular Cancer Therapeutics) Thursday June 5th 2014


51) Akt/Autophagy for Sorafenib Resistance in HCC (Molecular Cancer Therapeutics) Thursday June 5th 2014


52) Significance of the PELP1-mTOR Axis in Endocrine Resistance (Molecular Cancer Therapeutics) Thursday June 5th 2014


53) BAFF-R as Target for Antibody Therapy in ALL (Molecular Cancer Therapeutics) Thursday June 5th 2014


54) Noncytotoxic Treatment of Micrometastases (Molecular Cancer Therapeutics) Thursday June 5th 2014


55) AMG 330, a Novel CD3/CD33 BiTE Antibody (Molecular Cancer Therapeutics) Thursday June 5th 2014


56) Mesothelin-Targeting Antibody-Drug Con{#x0237}ugate (Molecular Cancer Therapeutics) Thursday June 5th 2014


57) Alternol Induces ROS-Dependent Apoptosis (Molecular Cancer Therapeutics) Thursday June 5th 2014


58) Tumor Targeting with Integrin {alpha}v{beta}3 and MMP-2 (Molecular Cancer Therapeutics) Thursday June 5th 2014


59) Immunotherapy for Hepatoma Using a Dual-Function Vector (Molecular Cancer Therapeutics) Thursday June 5th 2014


60) Small Molecule Inhibits ETV1 Acetylation and Function (Molecular Cancer Therapeutics) Thursday June 5th 2014


61) The JNK-MCL-1 Axis Contributes to the Anticancer Activity of MT189 (Molecular Cancer Therapeutics) Thursday June 5th 2014


62) Covalent EGFR Mutant-Selective Inhibitors (Molecular Cancer Therapeutics) Thursday June 5th 2014


63) A Small Molecule Inhibitor of EMT Pathways (Molecular Cancer Therapeutics) Thursday June 5th 2014


64) LY2857785 Is a CDK9 Inhibitor with Preclinical Antitumor Activity (Molecular Cancer Therapeutics) Thursday June 5th 2014


65) Coleusin Factor Restores Differentiation of Osteosarcoma (Molecular Cancer Therapeutics) Thursday June 5th 2014


66) Hec1 Inhibitor against Breast Cancer (Molecular Cancer Therapeutics) Thursday June 5th 2014


67) Inhibitors of Lactate Influx but Not Efflux (Molecular Cancer Therapeutics) Thursday June 5th 2014


68) Moguntinones--New Selective Inhibitors (Molecular Cancer Therapeutics) Thursday June 5th 2014


69) MELK, Key Kinase for Stem Cell Phenotype in Cancer Stem Cells (Molecular Cancer Therapeutics) Thursday June 5th 2014


70) Genomic Alterations of Primary and Recurrent Breast Cancer (Molecular Cancer Therapeutics) Tuesday May 6th 2014


71) Metallothioneins and Zinc Sensitize to Chemotherapy (Molecular Cancer Therapeutics) Tuesday May 6th 2014


72) nEGFR Is a Functional Molecular Target in TNBC (Molecular Cancer Therapeutics) Tuesday May 6th 2014


73) ERBB3 Signaling Promotes Resistance to EGFR Blockade (Molecular Cancer Therapeutics) Tuesday May 6th 2014


74) Cytosine Modifications in MGMT and Temozolomide Sensitivity (Molecular Cancer Therapeutics) Tuesday May 6th 2014


75) GALR2-Induced p38-MAPK Promotes Cytokine Secretion and Tumor (Molecular Cancer Therapeutics) Tuesday May 6th 2014


76) Hand-1 Suppresses Vascular Radiosensitivity (Molecular Cancer Therapeutics) Tuesday May 6th 2014


77) PUMA-Mediated Anticancer Effect of Aurora Kinase Inhibitors (Molecular Cancer Therapeutics) Tuesday May 6th 2014


78) The Role of TMEM98 in Chemoresistance of Hepatocellular Carcinoma (Molecular Cancer Therapeutics) Tuesday May 6th 2014


79) EMT Role in Docetaxel Resistance (Molecular Cancer Therapeutics) Tuesday May 6th 2014


80) The Hh Pathway and IPI-926 in Chondrosarcoma (Molecular Cancer Therapeutics) Tuesday May 6th 2014


81) JAK1/JAK2 Inhibition Suppresses Prostate Cancer Metastases (Molecular Cancer Therapeutics) Tuesday May 6th 2014


82) PIM Kinases Regulate CLL Survival and CXCR4 Surface Levels (Molecular Cancer Therapeutics) Tuesday May 6th 2014


83) Imatinib-Resistant Mast Cells Are Sensitive to Ponatinib (Molecular Cancer Therapeutics) Tuesday May 6th 2014


84) Embelin Reduces Colitis-Associated Tumorigenesis (Molecular Cancer Therapeutics) Tuesday May 6th 2014


85) Regulation of STAT5 Function by BRD2 in Leukemias (Molecular Cancer Therapeutics) Tuesday May 6th 2014


86) Novel Temozolomide Analog for Intracranial Breast Cancer (Molecular Cancer Therapeutics) Tuesday May 6th 2014


87) Olaparib Potentiates SN-38 Sensitivity in Colon Cancer Cells (Molecular Cancer Therapeutics) Tuesday May 6th 2014


88) CML and CXCR4 (Molecular Cancer Therapeutics) Tuesday May 6th 2014


89) BET Protein Antagonist and HDAC Inhibitor against AML (Molecular Cancer Therapeutics) Tuesday May 6th 2014


90) Protein Kinase D: A Novel Target for Colorectal Cancer Therapy (Molecular Cancer Therapeutics) Tuesday May 6th 2014


91) NVP-BYL719 PI3K{alpha} Inhibitor and Predictive Response Modeling (Molecular Cancer Therapeutics) Tuesday May 6th 2014


92) Preclinical PK/PD Evaluation of ON123300 in Brain Tumor (Molecular Cancer Therapeutics) Tuesday May 6th 2014


93) Antiangiogenic Activity of UPARANT (Molecular Cancer Therapeutics) Tuesday May 6th 2014


94) Pharmacodynamics and Antitumor Efficacy of XL765 (SAR245409) (Molecular Cancer Therapeutics) Tuesday May 6th 2014


95) Antitumor Effects of Supercritical Extract of Neem (Molecular Cancer Therapeutics) Tuesday May 6th 2014


96) Centmitor-1 Possesses Antimitotic Properties (Molecular Cancer Therapeutics) Tuesday May 6th 2014


97) PI3K{alpha} and PKC Inhibition Are Synergistic in Uveal Melanoma (Molecular Cancer Therapeutics) Tuesday May 6th 2014


98) Nab-Paclitaxel Combinations with Antiangiogenic Agents (Molecular Cancer Therapeutics) Tuesday May 6th 2014


View: prev | next

#RealTimeChem:

Announcements:


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()